M&A Deal Summary

Hibercell Acquires Genuity Science

On August 16, 2021, Hibercell acquired life science company Genuity Science for 100M USD

Acquisition Highlights
  • This is Hibercell’s 1st transaction in the Life Science sector.
  • This is Hibercell’s largest (disclosed) transaction.
  • This is Hibercell’s 1st transaction in the United States.
  • This is Hibercell’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2021-08-16
Target Genuity Science
Sector Life Science
Buyer(s) Hibercell
Deal Type Add-on Acquisition
Deal Value 100M USD

Target

Genuity Science

Boston, Massachusetts, United States
Genuity Science is a life science technology company that provides world-leading genomics and multi-omic analytics bolstered by an advanced artificial intelligence (AI) and machine learning (ML) platform to illuminate the underlying cause of cancer and other diseases. Genuity Science is based in Boston, Massachusetts.

Search 198,975 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hibercell

New York, New York, United States

Category Company
Founded 2019
Sector Life Science
DESCRIPTION

Hibercell is a clinical-stage biotechnology company focused on the advancement of novel therapeutic molecules that overcome the foundational molecular barriers that prevent patients from living longer, cancer-free lives. HiberCell’s approach utilizes the AI/ML to integrate both the genomic and phenotypic profiles of a patient’s cancer to generate deep insights that connect these data to clinical outcomes to identify the causal features that can be targeted with novel therapies that address the most common cause of cancer mortality: resistance, relapse, and metastasis. Hibercell was founded in 2019 and is based in New York City.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1